PHIO PHARMACEUTICALS CORP - COM NEW (PHIO)

CUSIP: 71880W303

Q4 2022 13F Holders as of 31 Dec 2022

Share change
-151,495
SEC-reported price per share
$0.37
Number of holders
11
Value change
-$67,976
Number of buys
3
Number of sells
10

Security key

71880W303

Report period

Q4 2022

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gerrit Dispersyn
Disclosed value leader
Gerrit Dispersyn
Comparable rows
0/14
Latest evidence
30 Sep 2022
3/4/5 13F Highest disclosed value: $320,614 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Gerrit Dispersyn has the largest disclosed position value at $320.6K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gerrit Dispersyn's linked filing trail.
Disclosed position value Top 5
Gerrit Dispersyn $320.6K
VANGUARD GROUP INC $125K
RENAISSANCE TECHNOLOGIES LLC $122K
GEODE CAPITAL MANAGEMENT, LLC $61K
Cetera Investment Advisers $43K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gerrit Dispersyn
3/4/5
President & CEO, Director
—
denominator unverified
$320,614
212,327 shares
— 01 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$125,000
218,192 shares
— 30 Sep 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$122,000
213,600 shares
— 30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$61,000
107,192 shares
— 30 Sep 2022
Cetera Investment Advisers
13F
Company
13F
—
denominator unverified
$43,000
75,000 shares
— 30 Sep 2022
H. Paul Dorman
3/4/5
Director
—
denominator unverified
$30,759
20,370 shares
— 15 Feb 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
575,219
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
12
Q4 2022 holders
11
Holder diff
-1
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .